Once-Weekly Semaglutide Formulations Effective and Safe for Indian Adults with Obesity

Obesity is a growing global health crisis, significantly increasing the risk of numerous comorbidities like type 2 diabetes, cardiovascular disease, and certain cancers. While Semaglutide, a GLP-1 receptor agonist, has demonstrated substantial efficacy in weight management across various populations, there remains a need for robust, region-specific data on its comparative efficacy and safety in diverse ethnic groups, particularly among Indian adults.